United States · FDA National Drug Code directory
Pyrantel Pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51072-088_7406132d-3c90-4bea-8a2d-c71873601f0c
- Product NDC
- 51072-088
- Form
- SUSPENSION
- Composition / generic term
- Pyrantel Pamoate
- Labeler
- Jefferson Labs
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20151121
- Source listing expiry
- 20261231
Source-listed ingredients
- PYRANTEL PAMOATE — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 946 mL in 1 BOTTLE (51072-088-00) · 51072-088-00
- 473 mL in 1 BOTTLE (51072-088-01) · 51072-088-01
- 946 mL in 1 BOTTLE (51072-088-02) · 51072-088-02
- 473 mL in 1 BOTTLE (51072-088-03) · 51072-088-03
- 237 mL in 1 BOTTLE (51072-088-04) · 51072-088-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →